In a nutshell, what does all of this week’s big FDA developments on stem cells and regenerative medicine mean for stem cell clinics? There’s much to be upbeat about so overall I’d say it’s good news, but I see three significant potential problems too. Dang. The good news is that the FDA seems determined to […]
Deconstructing FDA Mixed Bag Approach to Stem Cell Clinics Read More »
Are fat stem cells a drug? Today the FDA definitively indicated “yes” without leaving much of any room for exceptions on this question. This morning the FDA made a major announcement on stem cell policy regarding its current thinking on oversight of regenerative medicine and issued four guidances, including two each in final and in
Fat stem cells are drugs: new FDA final guidances Read More »
Nominations are now open for the 2017 Stem Cell Person of the Year Award, which will be our sixth such award. You can leave nominations as comments on this post or email them to me (see my email on our Contact page). The Stem Cell Person of the Year Award is an honor I give out
Stem Cell Person of the Year 2017 Award: Nominations Open Read More »
By Jeanne Loring There are ten million people in the world who have Parkinson’s disease. 125,000 of these are living in California. People with the disease often have to step away from their jobs because the main symptoms – tremor or freezing up of muscles – make it difficult to get through a whole day
On the threshold of cell therapy for Parkinson’s disease Read More »
Epidermis regeneration is an important approach to helping patients with a variety of serious skin problems that can arise due to genetic conditions or injuries such as severe burns. An exciting new Nature paper reports epidermis regeneration on a strikingly large-scale. The child who is the subject of the study suffers from a sometimes fatal genetic
Extraordinary epidermis regeneration in child via combo stem cell-gene therapy Read More »
Here are some stem cell reads for the weekend, ranging from media to research articles. TGIF! What are your stem cell or other science weekend reads? Let’s start with how difficult it is to make IPS cells from naked mole rats! Naked Mole Rat Cells Have a Stable Epigenome that Resists iPSC Reprogramming. It takes more than
Weekend Stem Cell Reads: Naked mole rats, geckos, brain gel, & more Read More »
How much does a stem cell treatment cost? $5,000 is a nice round number that is probably close to the mark on average, but the price varies a great deal and depends on many factors. Factors that influence perceived average price include what one actually sees as being under that umbrella term “stem cell treatment.” Does
Stem cell treatment cost: you often don’t get what you pay for Read More »
When I think of the promise of stem cells for diabetes, the privately held California stem cell firm ViaCyte is the first biotech that comes to mind now. It has promising stem cell clinical trial work building. Today’s post is a new interview with the company’s CEO Paul Laikind. For past posts on ViaCyte see here, which
ViaCyte Interview on Diabetes Stem Cell Trials & Cool Role of Gore-Tex Tech Read More »
For-profit stem cell clinic secrets are bad news for patients. Stem cell clinics are in the business of making profits above all else and to make steady money they need a strong flow of patients as their paying customers for their non-FDA approved offerings. In order to keep the money pouring in, some of the
Shh! 10 stem cell clinic secrets kept from patients Read More »
Bulls-eye! Here are some stem cell weekend reads including both interesting new papers & news headlines. Of course, this week also had stem cell awareness day and I wrote about 10 key issues for the field for the coming 10 years! Weekend reads Papers Chromatin and Single-Cell RNA-Seq Profiling Reveal Dynamic Signaling and Metabolic Transitions during
TGIF stem cell weekend reads of papers & news Read More »